- ►diabetesjournals.org J Szendroedi, C Anderwald, M Krssak, M … - Diabetes care, 2009 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—We performed a randomized, double-blind,
placebo-controlled, single-center study. Twenty patients with type 2 diabetes
received 80 mg simvastatin (BMI 29 ± 4 kg/m 2 , age 55 ± 6 years) or ... Cited by 4 - Related articles - All 4 versions
NE Gilhus - Nature clinical practice. Neurology, 2009 - 万方数据资源系统 This Practice Point commentary discusses a retrospective study by Oh et al. in
which the consequences of using statins in patients with myasthenia gravis (MG)
were examined. Out of 170 patients with MG seen at a single hospital center ... Cited by 2 - Related articles - All 4 versions
R Sukhija, S Prayaga, M Marashdeh, Z Bursac … - Journal of Investigative Medicine, 2009 - journals.lww.com Copyright @ 200 American Federation for Medical Research. Unauthorized
reproduction of this article is prohibited. 9 ... Effect of Statins on Fasting
Plasma Glucose in Diabetic ... Rishi Sukhija, MD,* Sastry Prayaga, MD,* ... Cited by 3 - Related articles - All 3 versions
R Zeiser, K Maas, S Youssef, C Durr, L … - Immunology, 2009 - pt.wkhealth.com Summary: The 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitors
(statins) interfere with the mevalonate pathway. While initially developed for
their lipid-lowering properties, statins have been extensively investigated ... Cited by 2 - Related articles - All 5 versions
DJ Jang, SW Park, BK Kaang - BMB Rep, 2009 - jbmb.or.kr *Corresponding author. Tel: 82-2-880-7525; Fax: 82-2-884-9577; E-mail:
kaang@snu.ac.kr ... Keywords: Cholesterol, Lipid Binding, Palmitoylation,
Phosphoino- sitide, Synaptic vesicle ... The role of lipid binding for the ... Cited by 3 - Related articles - View as HTML - All 6 versions
S Greenfeder - Current medicinal chemistry, 2009 - ingentaconnect.com Department of Cardiovascular and Metabolic Diseases, Schering-Plough Research
Institute, USA Abstract: For decades, the focus of therapy to mitigate
cardiovascular risk has been to lower low density lipoprotein cho- lesterol ... Cited by 2 - Related articles - All 4 versions
F de Meyer, B Smit - Proceedings of the National Academy of Sciences, 2009 - nihongo.j-talk.com Cholesterol plays an important role in regulating the properties of phospholipid
membranes. To obtain a detailed understanding of the lipid–cholesterol
interactions, we have developed a mesoscopic water–lipid–cholesterol ... Cited by 2 - Related articles - All 7 versions
F Sivas, E Alemdaroğlu, E Elverici, T Kuluğ, K … - Rheumatology International, 2009 - Springer Page 1. Rheumatol Int (2009) 29:885–890 DOI 10.1007/s00296-008-0784-4 123 ORIGINAL
ARTICLE Serum lipid proWle: its relationship with osteoporotic ... Cited by 2 - Related articles - All 2 versions
U Ravnskov, KS McCully - Annals of Clinical & Laboratory Science, 2009 - nmsociety.org Abstract. Little attention has been paid to the function of lipoproteins as part
of a nonspecific immune defense system that binds and inactivates microbes and
their toxins effectively by complex formation. Because of high ... Cited by 2 - Related articles - View as HTML - All 9 versions
